These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28929177)

  • 21. Restrictions on import of drugs for personal use within the European single market.
    Mäkinen MM; Rautava PT; Forsström JJ
    Eur J Public Health; 2002 Dec; 12(4):244-8. PubMed ID: 12506498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health and economic consequences of counterfeit drugs.
    Seiter A
    Clin Pharmacol Ther; 2009 Jun; 85(6):576-8. PubMed ID: 19451909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counterfeit pharmaceutical products.
    World Health Forum; 1998; 19(2):213-4. PubMed ID: 9652226
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing the problem of counterfeit medications in the United Kingdom.
    Jackson G; Patel S; Khan S
    Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global perspectives on ensuring the safety of pharmaceutical products in the distribution process
.
    Jeong S; Ji E
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):12-23. PubMed ID: 29154750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncology drugs in the crosshairs of pharmaceutical crime.
    Venhuis BJ; Oostlander AE; Giorgio DD; Mosimann R; du Plessis I
    Lancet Oncol; 2018 Apr; 19(4):e209-e217. PubMed ID: 29611529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Internet-ordered viagra (sildenafil citrate) is rarely genuine.
    Campbell N; Clark JP; Stecher VJ; Goldstein I
    J Sex Med; 2012 Nov; 9(11):2943-51. PubMed ID: 22925379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
    Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
    BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fighting falsified medicines with paperwork - a historic review of Danish legislation governing distribution of medicines.
    Borup R; Kaae S; Minssen T; Traulsen J
    J Pharm Policy Pract; 2016; 9():30. PubMed ID: 27713830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies' professionals in the European Economic Area.
    WŁodarczak U; Swieczkowski D; Religioni U; Jaguszewski M; Krysinski J; Merks P
    Pharm Pract (Granada); 2017; 15(4):1031. PubMed ID: 29317918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines.
    Anđelković M; Björnsson E; De Bono V; Dikić N; Devue K; Ferlin D; Hanževački M; Jónsdóttir F; Shakaryan M; Walser S
    BMC Health Serv Res; 2017 Jun; 17(1):419. PubMed ID: 28633634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A counterfeit drug treaty: great idea, wrong implementation.
    Bate R; Attaran A
    Lancet; 2010 Oct; 376(9751):1446-8. PubMed ID: 21036261
    [No Abstract]   [Full Text] [Related]  

  • 36. The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.
    Świeczkowski D; Zdanowski S; Merks P; Szarpak Ł; Vaillancourt R; Jaguszewski MJ
    Cardiol J; 2022; 29(1):133-139. PubMed ID: 33346374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Falsification of biotechnology drugs: current dangers and/or future disasters?
    Janvier S; De Spiegeleer B; Vanhee C; Deconinck E
    J Pharm Biomed Anal; 2018 Nov; 161():175-191. PubMed ID: 30165334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO to set up international task force on counterfeit drugs.
    Zarocostas J
    BMJ; 2006 Feb; 332(7539):444. PubMed ID: 16497756
    [No Abstract]   [Full Text] [Related]  

  • 40. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.